Brought to you by 
Transgene raises $52.7mm through rights offering
02 Apr 2003
Executive Summary
Transgene (gene therapy) netted $52.7mm (Euro61.4mm) through a rights offering of 4.2mm ordinary shares at $13.21 each. In April the company was looking for $72mm (Euro79.5mm) for up to 5.3mm ordinary shares at $13.56 (Euro15) apiece (or 15.9mm American Depository Shares with one ordinary share equaling three ADSs).
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Transgene raises $52.7mm through rights offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice